Form 4: Nu Skin Director Sells Shares Under 10b5-1 Plan

Nu Skin Enterprises Director Daniel W. Campbell sold over 32,000 shares of Class A Common Stock in pre-planned transactions.

Summary

• Daniel W. Campbell, a Director of Nu Skin Enterprises, Inc. (NUS), sold a total of 32,437 shares of Class A Common Stock on August 29, 2025.
• The sales were executed pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
• 9,046 shares were sold directly at a weighted-average price of $12.12 per share, with prices ranging from $12.11 to $12.12.
• An additional 23,391 shares were sold indirectly through an irrevocable family trust at a weighted-average price of $12.10 per share, with prices ranging from $12.10 to $12.12.
• Following these transactions, Mr. Campbell directly owns 39,216 shares and indirectly owns 53,375 shares through an irrevocable family trust and 10,010 shares through a limited liability company.

Sentiment

Score: 4

Explanation: The sale of shares by a director, even under a 10b5-1 plan, generally indicates a reduction in insider ownership, which is not a strong positive signal. However, the pre-planned nature mitigates the negative impact compared to an unplanned sale, suggesting it's a routine financial event rather than a reflection of new negative company information.

Positives

• The transactions were conducted under a Rule 10b5-1(c) plan, indicating they were pre-scheduled and not a reaction to recent non-public information, which can mitigate negative investor perception.

Negatives

• A director's sale of a significant number of shares reduces insider ownership, which can sometimes be perceived negatively by investors as it signals a reduction in management's direct financial stake in the company.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which is limited to reporting insider transactions.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context. Insider sales can be a routine part of executive compensation and financial planning, especially when conducted under a 10b5-1 plan, and do not necessarily reflect a change in the company's operational performance or industry trends.

Related Party Transactions

• Sales of 23,391 shares were made indirectly through an irrevocable family trust. An additional 10,010 shares are indirectly owned through a limited liability company owned and controlled by the Reporting Person and his spouse.

Stakeholder Impact

• Shareholders may perceive a director's sale of shares, even if pre-planned, as a slight negative signal regarding future stock performance, though the impact is generally limited for routine 10b5-1 sales and does not typically indicate a fundamental shift in company prospects.

Key Dates

Recommendation

The filing reports a pre-planned insider sale by a director, which is a routine event under a 10b5-1 plan and does not typically signal new material information about the company's prospects. While a reduction in insider ownership is generally not a positive, the pre-scheduled nature means it shouldn't be interpreted as a strong negative signal for the company's fundamentals. Therefore, a 'hold' recommendation is appropriate as this specific filing does not provide a strong catalyst for a 'buy' or 'sell' decision.

Keywords

Nu Skin Enterprises, NUS, Insider Sale, Form 4, Director, Stock Transaction, 10b5-1 Plan, Daniel W. Campbell